Many patients can safely continue GLP-1 medications with appropriate precautions, but the decision depends on individual risk factors including dose escalation status, gastrointestinal symptoms, and type of surgery
Surgery also typically requires medication adjustments always handled individually by a doctor
The data in Table 1 reflect the exposure of 1102 adults with type 1 diabetes to TRESIBA with a mean exposure duration to TRESIBA of 34 weeks in three open-label trials
Key TakeawaysMore folks are using weight-loss drugs to drop pounds prior to bariatric surgeryGLP-1 drug use rose 16-fold among patients about to undergo weight-loss surgeryThis represents a shift in how weight-loss patients view their treatment options, researchers said.WEDNESDAY, Oct
In breast cancer and possibly other tumor types, HRD1 reportedly mediates ERAD of insulin-like growth factor-1 (IGF-1R), 471 the platelet isoform of phosphofructokinase (PFKP), 472 and carnitine palmitoyltransferase 2 (CPT2), 473 which are key pathways involved in breast cancer pathogenesis
